When the number of shares on issue changes as companies raise required capital to develop the business, or consolidates (as NEU did in November 2017), focusing on market capitalisation is infinitely more informative than the share price.
A number of posters have been making comments on the contemporary SP, as if it was directly relatable to an historic SP, when there was a different number of SOI.
It may be more useful to consider the MC when setting expectations about a company's worth. The chart below shows the monthly MC from January 2013 (just prior to my first investment). It shows that NEU is already valued considerable more than any previous peak.
- Forums
- ASX - By Stock
- NEU
- Market Capitalisation is a Better Valuation Metric Than Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$15.17

Market Capitalisation is a Better Valuation Metric Than Share Price
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$15.17 |
Change
0.000(0.00%) |
Mkt cap ! $1.888B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1268 | $18.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.25 | 17 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1268 | 18.200 |
2 | 1352 | 15.820 |
1 | 5 | 15.550 |
1 | 6986 | 15.350 |
1 | 1 | 15.290 |
Price($) | Vol. | No. |
---|---|---|
14.250 | 17 | 2 |
14.590 | 1600 | 4 |
15.150 | 42 | 1 |
15.180 | 117 | 1 |
15.190 | 117 | 1 |
Last trade - 09.36am 22/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |